Partnerships, Licensing, Investments and M&A Deals Pipeline Insight and Therapeutic Assessment Reviewed

Posted on 2017-08-11 by Mark Hub in Healthcare // 0 Comments

Albany, US, 2017-Aug-11 — /EPR Network/ —Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Partnerships, Licensing, Investments and M&A Deals and Trends for May 2017 in Pharmaceuticals”. This report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry.

Request For Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1287566

The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in May 2017. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalDatas proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

The pharmaceutical and healthcare industry reported an increase in the number of deals and deal values in May 2017. The industry reported 373 deals worth USD37.8 billion in May 2017, compared to 307 deals worth USD21.5 billion in April 2017. The oncology therapeutics market remained at the top in deal activity in May 2017 with 126 deals. In second place, central nervous system therapeutics market reported 84 deals. Licensing agreements in pharmaceutical and healthcare industry registered a decrease in upfront payments. The segment reported USD199.7m as upfront payments in May 2017, compared to USD395.6m in 2017. The number of deals in North America increased to 229 in May 2017 from 192 in April 2017.

Browse Full Report With TOC: http://www.marketresearchhub.com/report/partnerships-licensing-investments-and-manda-deals-and-trends-for-may-2017-in-pharmaceuticals-report.html

Scope

– Analysis of the market trends for the pharmaceutical industry in the global arena.
– Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women’s health segments.
– Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
– Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
– Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
– Analysis of partnership and licensing deals based on clinical stage of development of products.
– Summary of the pharmaceutical deals globally in the six months.
– Information on the top deals happened in the pharmaceutical industry.
– Geographies covered include – North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
– League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Reasons to buy

– Enhance your decision making capability in a more rapid and time sensitive manner.
– Find out the major deal performing segments for investments in your industry.
– Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
– Identify companies that are aggressively looking to raise capital in the market
– Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
– Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
– Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
– Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
– Identify growth segments and opportunities in each region within the industry.
– Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.

Make an Enquiry: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1287566

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick